Hawaii 2022 Regular Session

Hawaii House Bill HB2515

Introduced
1/26/22  
Refer
1/28/22  
Report Pass
2/10/22  
Refer
2/10/22  
Report Pass
2/18/22  
Refer
2/18/22  
Report Pass
3/3/22  
Engrossed
3/3/22  
Refer
3/8/22  
Report Pass
3/24/22  
Refer
3/24/22  
Report Pass
4/8/22  
Enrolled
5/5/22  
Chaptered
6/27/22  

Caption

Relating To The Department Of Health.

Impact

If enacted, HB2515 is likely to have significant implications for health policy in Hawaii. The establishment of a dedicated testing laboratory would streamline the process of disease detection and environmental monitoring, providing more timely and accurate data to health officials. This ability to conduct high-complexity testing within the state could improve the overall healthcare response during public health crises, making it an essential asset for safeguarding communities' health and well-being.

Summary

House Bill 2515 aims to enhance public health capabilities in Hawaii by establishing a state-of-the-art testing laboratory within the Department of Health. The bill mandates the department to operate a facility that can conduct tests for diseases as well as assessing air and water quality issues. This initiative seeks to ensure compliance with federal standards, as outlined in the Clinical Laboratories Improvement Amendments, thereby bolstering the state’s ability to monitor and respond to health-related challenges more effectively.

Sentiment

Support for HB2515 appears strong among public health advocates and officials who recognize the necessity of improved testing capabilities in today's health landscape. The sentiment is likely rooted in the understanding that enhanced testing can lead to better health outcomes and a more robust public health infrastructure. However, there may be concerns regarding funding and resource allocation, as the bill allows the department to obtain and expend federal funds for the laboratory, which could spark discussions about dependency on federal resources for state health initiatives.

Contention

Despite the positive reception from health stakeholders, there could be points of contention related to the operationalization of the testing laboratory. Questions around implementation timelines, budget constraints, and ensuring consistent federal funding may arise. Additionally, stakeholders might debate the extent of state involvement in laboratory testing and the potential implications this has for local health agencies that presently manage these services. Nonetheless, the overarching objective of enhancing health monitoring systems remains a critical focus of this legislation.

Companion Bills

HI HB1785

Same As Relating To Tourism Governance.

Similar Bills

CA AB2107

Clinical laboratory technology: remote review.

CA SB962

Healing arts: clinical laboratory technology: moderate-complexity laboratories.

CA SB1267

Clinical laboratories.

CA AB526

Dentists and podiatrists: clinical laboratories and vaccines.

CA SB409

Pharmacy practice: testing.

CA AB3009

Hazardous materials: lead-based paint.

CA AB2281

Clinical laboratories: licensed medical laboratory technicians.

CA AB1741

Healing arts: clinical laboratories: personnel.